Risk factors for myopic choroidal neovascularization-related macular atrophy after anti-VEGF treatment.
Ki Woong BaeDong Ik KimBo Hee KimBaek-Lok OhEun Kyoung LeeChang Ki YoonUn Chul ParkPublished in: PloS one (2022)
In mCNV eyes treated with intravitreal anti-VEGF agents, older age and greater mCNV size at baseline were risk factors for the development of MA during long-term follow-up, which was associated with a poor visual prognosis.